• 6767 Bertner Ave, Mitchell Basic Science Research Building

    77030 Houston

    United States

  • 14101 Citations
  • 59 h-Index
19992019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Scott Kopetz is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Colorectal Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Mutation Medicine & Life Sciences
Survival Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences
Liver Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1999 2019

7 Citations (Scopus)

Anti-EGFR-resistant clones decay exponentially after progression: Implications for anti-EGFR re-challenge

Parseghian, C., Loree, J. M., Morris, V. K., Liu, X., Clifton, K. K., Napolitano, S., Henry, J. T., Pereira, A. A., Vilar Sanchez, E., Johnson, B., Kee, B. K., Raghav, K. P. S., Dasari, N. V., Wu, J. Y., Garg, N., Raymond, V. M., Banks, K. C., Talasaz, A. A., Lanman, R. B., Strickler, J. H. & 4 others, Hong, D. S., Corcoran, R. B., Overman, M. J. & Kopetz, E. S., Feb 1 2019, In : Annals of Oncology. 30, 2, p. 243-249 7 p.

Research output: Contribution to journalArticle

Epidermal Growth Factor Receptor
Clone Cells
Mutation
Half-Life
Colorectal Neoplasms
2 Citations (Scopus)
Colorectal Neoplasms
Explosions
Protein Sequence Analysis
Computational Biology
Natural History
15 Citations (Scopus)

Binimetinib, encorafenib, and cetuximab triplet therapy for patients with BRAF V600E–mutant metastatic colorectal cancer: Safety lead-in results from the phase III BEACON Colorectal Cancer Study

Van Cutsem, E., Huijberts, S., Grothey, A., Yaeger, R., Cuyle, P. J., Elez, E., Fakih, M., Montagut, C., Peeters, M., Yoshino, T., Wasan, H., Desai, J., Ciardiello, F., Gollerkeri, A., Christy-Bittel, J., Maharry, K., Sandor, V., Schellens, J. H. M., Kopetz, S. & Tabernero, J., Jan 1 2019, In : Journal of Clinical Oncology. 37, 17, p. 1460-1469 10 p.

Research output: Contribution to journalArticle

Open Access
Colorectal Neoplasms
Safety
Disease-Free Survival
Therapeutics
Survival
2 Citations (Scopus)

Biomarker-guided therapy for colorectal cancer: strength in complexity

Sveen, A., Kopetz, S. & Lothe, R. A., Jan 1 2019, In : Nature Reviews Clinical Oncology.

Research output: Contribution to journalReview article

Colorectal Neoplasms
Biomarkers
Therapeutics
Point Mutation
Decision Making

Can Circulating Tumor DNA in Early-Stage Colorectal Cancer Be More Than a Prognostic Biomarker?

Morris, V. K., Dasari, N. V. & Kopetz, S., Aug 1 2019, In : JAMA Oncology. 5, 8, p. 1101-1103 3 p.

Research output: Contribution to journalEditorial

Colorectal Neoplasms
Biomarkers
DNA
Neoplasms